Ulipristal acetate versus conventional management of heavy menstrual bleeding (HMB; including uterine fibroids): a randomised controlled trial and exploration of mechanism of action (UCON trial)

Williams, Alistair (Principal Investigator)

School of Population Health Sciences

Status	Finished
Effective start/end date	1/10/14 → 31/10/21

Funding

UK central government bodies/local authorities, health and hospital authorities: £24,125.00

Ulipristal acetate versus levonorgestrel-releasing intrauterine system for heavy menstrual bleeding (UCON): a randomised controlled phase III trial
Whitaker, L. H. R., Middleton, L. J., Daniels, J. P., Williams, A. R. W., Priest, L., Odedra, S., Cheed, V., Stubbs, C. E., Clark, T. J., Lumsden, M.-A., Hapangama, D. K., Bhattacharya, S., Smith, P. P., Nicholls, E. P., Roberts, N., Semple, S. I., Saraswat, L., Walker, J., Chodankar, R. R. & Critchley, H. O. D., 1 Jun 2023, In: EClinicalMedicine. 60, 101995.
Research output: Contribution to journal › Article › peer-review

Open Access
File